Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Phlegmasia cerulea dolens

From Wikipedia, the free encyclopedia
Medical condition
Phlegmasia cerulea dolens
A person with a two hour history of phlegmasia cerulea dolens (left leg, right side of image)

Phlegmasia cerulea dolens (PCD) (literally: 'painful blue inflammation'), not to be confused with precedingphlegmasia alba dolens, is an uncommon severe form of lower extremitydeep venous thrombosis (DVT) that obstructs blood outflow from a vein. Upper extremity PCD is less common, occurring in under 10% of all cases.[1] PCD results from extensivethrombotic occlusion (blockage by athrombus) of extremity veins, most commonly aniliofemoral DVT, of theiliac vein and/orcommon femoral vein.[2][3] It is a medical emergency requiring immediate evaluation and treatment.

Symptoms and signs

[edit]

Primary symptoms

[edit]

It is characterized by progressive lower extremity edema distal to the thigh, tight shiny skin,cyanosis (inadequate blood oxygenation),petechiae orpurpura, and sudden severe pain of the affected limb in proportion to the level of venous blockage. Patients often have difficulty walking.Blisters, bullae,paresthesias, and motor weakness may develop in severe cases, along with gangrene in ~50% of cases.[4][5] Distal pulses are palpable early on but may diminish over time, anddoppler signal can be usually heard throughout disease progression.[6] The left limb is more commonly affected due to its vascular anatomy (the rightinternal iliac artery directly overlies the left iliac vein).[7][8]

Associated diseases

[edit]

PCD is associated with an underlyingmalignancy in 20-40% of cases.[9] There is a high risk of massivepulmonary embolism, even underanticoagulation.[10]

Etiology

[edit]

Risk factors, present in around 50% of documented cases, include malignancy,hyper-coagulable states,cardiac disease,venous stasis, venous insufficiency,May-Thurner syndrome (right iliac artery compressing the left iliac vein that runs beneath it), surgery, trauma,pregnancy,inferior vena cava (IVC) filter, hormone therapy,oral contraceptives, prolonged immobilization,inflammatory bowel disease,heart failure, and central venous catheters. Etiology is unknown in ~10% of PCD cases.[11][12][13]

Deep vein thrombosis of the left external iliac in a person with bladder cancer resulting in this condition. (Author James Heilman, MD, 2016)

Pathophysiology

[edit]

When athrombus occludes an extremityvein, pressure backs up in the venous system leading plasma fluid to leak out into theinterstitium of the affected limb. This increases the pressure of that limb compartment, which can collapse the arteries and lead to acuteischemia,gangrene,hypovolemia, and hemodynamic instability.[14][15]

Diagnosis

[edit]

PCD is best diagnosed with contrast venography, butvenous duplex ultrasonography is used more commonly in clinical practice. Magnetic resonance and computed tomographyvenography can also be used.[16]

Differential Diagnosis

[edit]

DDx is as follows:[17]

Treatment

[edit]

Treatment for PCD includes immediateanticoagulation, fluidresuscitation, bed rest, limb elevation above 60º, limb wrap to reduce pain and edema, and either catheter-basedthrombolysis, percutaneous transluminalangioplasty, or surgical venousthrombectomy +/-fasciotomy to remove theblood clot.[18][19][20][21] Some people also suggest anIVC filter before thrombolysis.[22]

Prognosis

[edit]

PCD is fully reversible if the causalvenous thrombus is promptly removed.[23] In the 40-60% of people who go on to develop venous gangrene, there is a 20-50% risk of amputation and 20-40% mortality rate.[24][25] Following PCD resolution patients are more likely to develop venous insufficiency andpost-thrombotic syndrome[26]

A grading system has been established[by whom?]:[27][28]

  • Grade I = non-complicated (noblistering, strong sensory-motor function and strong distal pulses)
  • Grade II = impending venousgangrene (blistering, weak sensory-motor function and weak distal pulses)
  • Grade III = venous gangrene

Epidemiology

[edit]

PCD is most likely to occur in people in their 50s and 60s, but can occur as early as 6 months old. There is slight male predominance of around 1.5:1.[29][30]

History

[edit]

This phenomenon was first discovered by Fabricus Hildanius in the16th century, and was officially termed "phlegmasia cerulea dolens" by Gregoire in 1938.[31][32]Phlegmasia originates from theGreek rootphlegma (inflammation),cerulea originates fromLatin rootcaeruleus (dark blue), anddolens originates from Latin worddolens (suffering).[33]

References

[edit]
  1. ^Greenberg, Jacques; Troutman, Douglas A.; Shubinets, Valeriy; Dougherty, Matthew J.; Calligaro, Keith D. (February 2016)."Phlegmasia Cerulea Dolens in the Upper Extremity: A Case Report and Systematic Review and Outcomes Analysis".Vascular and Endovascular Surgery.50 (2):98–101.doi:10.1177/1538574416631645.ISSN 1538-5744.PMID 26912398.S2CID 29270577.
  2. ^Rutherford's vascular surgery and endovascular therapy. Anton N. Sidawy, Bruce A. Perler (9th ed.). Philadelphia, PA. 2019.ISBN 978-0-323-58130-1.OCLC 1037557259.{{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: others (link)
  3. ^Gardella, Layne; Faulk, JimBob (2020),"Phlegmasia Alba And Cerulea Dolens",StatPearls, Treasure Island (FL): StatPearls Publishing,PMID 33085284, retrieved2021-02-11
  4. ^Gardella, Layne; Faulk, JimBob (2020),"Phlegmasia Alba And Cerulea Dolens",StatPearls, Treasure Island (FL): StatPearls Publishing,PMID 33085284, retrieved2021-02-11
  5. ^Rutherford's vascular surgery and endovascular therapy. Anton N. Sidawy, Bruce A. Perler (9th ed.). Philadelphia, PA. 2019.ISBN 978-0-323-58130-1.OCLC 1037557259.{{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: others (link)
  6. ^Rutherford's vascular surgery and endovascular therapy. Anton N. Sidawy, Bruce A. Perler (9th ed.). Philadelphia, PA. 2019.ISBN 978-0-323-58130-1.OCLC 1037557259.{{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: others (link)
  7. ^Chinsakchai, Khamin; ten Duis, Kaj; Moll, Frans L.; de Borst, Gert J. (January 2011)."Trends in Management of Phlegmasia Cerulea Dolens".Vascular and Endovascular Surgery.45 (1):5–14.doi:10.1177/1538574410388309.ISSN 1538-5744.PMID 21193462.S2CID 64951.
  8. ^Gardella, Layne; Faulk, JimBob (2020),"Phlegmasia Alba And Cerulea Dolens",StatPearls, Treasure Island (FL): StatPearls Publishing,PMID 33085284, retrieved2021-02-11
  9. ^Gardella, Layne; Faulk, JimBob (2020),"Phlegmasia Alba And Cerulea Dolens",StatPearls, Treasure Island (FL): StatPearls Publishing,PMID 33085284, retrieved2021-02-11
  10. ^John T. Owings (December 2005)."Management of Venous Thromboembolism".ACS Surgery. American College of Surgeons. Archived fromthe original on January 27, 2012. RetrievedJanuary 16, 2012.
  11. ^Greenberg, Jacques; Troutman, Douglas A.; Shubinets, Valeriy; Dougherty, Matthew J.; Calligaro, Keith D. (February 2016)."Phlegmasia Cerulea Dolens in the Upper Extremity: A Case Report and Systematic Review and Outcomes Analysis".Vascular and Endovascular Surgery.50 (2):98–101.doi:10.1177/1538574416631645.ISSN 1538-5744.PMID 26912398.S2CID 29270577.
  12. ^Chinsakchai, Khamin; ten Duis, Kaj; Moll, Frans L.; de Borst, Gert J. (January 2011)."Trends in Management of Phlegmasia Cerulea Dolens".Vascular and Endovascular Surgery.45 (1):5–14.doi:10.1177/1538574410388309.ISSN 1538-5744.PMID 21193462.S2CID 64951.
  13. ^Gardella, Layne; Faulk, JimBob (2020),"Phlegmasia Alba And Cerulea Dolens",StatPearls, Treasure Island (FL): StatPearls Publishing,PMID 33085284, retrieved2021-02-11
  14. ^Gardella, Layne; Faulk, JimBob (2020),"Phlegmasia Alba And Cerulea Dolens",StatPearls, Treasure Island (FL): StatPearls Publishing,PMID 33085284, retrieved2021-02-11
  15. ^Chang, Grace; Yeh, James J. (July 2014). "Fulminant phlegmasia cerulea dolens with concurrent cholangiocarcinoma and a lupus anticoagulant: a case report and review of the literature".Blood Coagulation & Fibrinolysis.25 (5):507–511.doi:10.1097/MBC.0000000000000057.ISSN 1473-5733.PMID 24553060.S2CID 10642849.
  16. ^Chinsakchai, Khamin; ten Duis, Kaj; Moll, Frans L.; de Borst, Gert J. (January 2011)."Trends in Management of Phlegmasia Cerulea Dolens".Vascular and Endovascular Surgery.45 (1):5–14.doi:10.1177/1538574410388309.ISSN 1538-5744.PMID 21193462.S2CID 64951.
  17. ^Gardella, Layne; Faulk, JimBob (2020),"Phlegmasia Alba And Cerulea Dolens",StatPearls, Treasure Island (FL): StatPearls Publishing,PMID 33085284, retrieved2021-02-11
  18. ^Chinsakchai, Khamin; ten Duis, Kaj; Moll, Frans L.; de Borst, Gert J. (January 2011)."Trends in Management of Phlegmasia Cerulea Dolens".Vascular and Endovascular Surgery.45 (1):5–14.doi:10.1177/1538574410388309.ISSN 1538-5744.PMID 21193462.S2CID 64951.
  19. ^Rutherford's vascular surgery and endovascular therapy. Anton N. Sidawy, Bruce A. Perler (9th ed.). Philadelphia, PA. 2019.ISBN 978-0-323-58130-1.OCLC 1037557259.{{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: others (link)
  20. ^Gardella, Layne; Faulk, JimBob (2020),"Phlegmasia Alba And Cerulea Dolens",StatPearls, Treasure Island (FL): StatPearls Publishing,PMID 33085284, retrieved2021-02-11
  21. ^Chang, Grace; Yeh, James J. (July 2014). "Fulminant phlegmasia cerulea dolens with concurrent cholangiocarcinoma and a lupus anticoagulant: a case report and review of the literature".Blood Coagulation & Fibrinolysis.25 (5):507–511.doi:10.1097/MBC.0000000000000057.ISSN 1473-5733.PMID 24553060.S2CID 10642849.
  22. ^Chinsakchai, Khamin; ten Duis, Kaj; Moll, Frans L.; de Borst, Gert J. (January 2011)."Trends in Management of Phlegmasia Cerulea Dolens".Vascular and Endovascular Surgery.45 (1):5–14.doi:10.1177/1538574410388309.ISSN 1538-5744.PMID 21193462.S2CID 64951.
  23. ^Rutherford's vascular surgery and endovascular therapy. Anton N. Sidawy, Bruce A. Perler (9th ed.). Philadelphia, PA. 2019.ISBN 978-0-323-58130-1.OCLC 1037557259.{{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: others (link)
  24. ^Gardella, Layne; Faulk, JimBob (2020),"Phlegmasia Alba And Cerulea Dolens",StatPearls, Treasure Island (FL): StatPearls Publishing,PMID 33085284, retrieved2021-02-16
  25. ^Chinsakchai, Khamin; ten Duis, Kaj; Moll, Frans L.; de Borst, Gert J. (January 2011)."Trends in Management of Phlegmasia Cerulea Dolens".Vascular and Endovascular Surgery.45 (1):5–14.doi:10.1177/1538574410388309.ISSN 1538-5744.PMID 21193462.S2CID 64951.
  26. ^Gardella, Layne; Faulk, JimBob (2020),"Phlegmasia Alba And Cerulea Dolens",StatPearls, Treasure Island (FL): StatPearls Publishing,PMID 33085284, retrieved2021-02-11
  27. ^Chinsakchai, Khamin; ten Duis, Kaj; Moll, Frans L.; de Borst, Gert J. (January 2011)."Trends in Management of Phlegmasia Cerulea Dolens".Vascular and Endovascular Surgery.45 (1):5–14.doi:10.1177/1538574410388309.ISSN 1538-5744.PMID 21193462.S2CID 64951.
  28. ^Chang, Grace; Yeh, James J. (July 2014). "Fulminant phlegmasia cerulea dolens with concurrent cholangiocarcinoma and a lupus anticoagulant: a case report and review of the literature".Blood Coagulation & Fibrinolysis.25 (5):507–511.doi:10.1097/MBC.0000000000000057.ISSN 1473-5733.PMID 24553060.S2CID 10642849.
  29. ^Chinsakchai, Khamin; ten Duis, Kaj; Moll, Frans L.; de Borst, Gert J. (January 2011)."Trends in Management of Phlegmasia Cerulea Dolens".Vascular and Endovascular Surgery.45 (1):5–14.doi:10.1177/1538574410388309.ISSN 1538-5744.PMID 21193462.S2CID 64951.
  30. ^Gardella, Layne; Faulk, JimBob (2020),"Phlegmasia Alba And Cerulea Dolens",StatPearls, Treasure Island (FL): StatPearls Publishing,PMID 33085284, retrieved2021-02-11
  31. ^Gardella, Layne; Faulk, JimBob (2020),"Phlegmasia Alba And Cerulea Dolens",StatPearls, Treasure Island (FL): StatPearls Publishing,PMID 33085284, retrieved2021-02-11
  32. ^Chinsakchai, Khamin; ten Duis, Kaj; Moll, Frans L.; de Borst, Gert J. (January 2011)."Trends in Management of Phlegmasia Cerulea Dolens".Vascular and Endovascular Surgery.45 (1):5–14.doi:10.1177/1538574410388309.ISSN 1538-5744.PMID 21193462.S2CID 64951.
  33. ^Rutherford's vascular surgery and endovascular therapy. Anton N. Sidawy, Bruce A. Perler (9th ed.). Philadelphia, PA. 2019.ISBN 978-0-323-58130-1.OCLC 1037557259.{{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: others (link)

External links

[edit]
Classification
External resources
Retrieved from "https://en.wikipedia.org/w/index.php?title=Phlegmasia_cerulea_dolens&oldid=1301401966"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp